One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1016/s0090-8258(22)01258-6
Copy DOI Journal: Gynecologic Oncology |  Publication Date: Aug 1, 2022 |
 Citations: 1 |
Affiliation: University of Oklahoma Health Sciences Center, Tennessee Oncology, Sarah Cannon, Dartmouth–Hitchcock Medical Center, Cotton (United States), Western Pennsylvania Hospital, Florida Cancer Specialists & Research Institute, University of Washington, GlaxoSmithKline (United States), Riverside Methodist Hospital, University of California, Los Angeles, Alaska Women's Cancer Care, University of RochesterOVARIO, A Phase 2 Study of Niraparib + Bevacizumab in Advanced Ovarian Cancer Following Front-Line Platinum-Based Chemotherapy with Bevacizumab: Updated Analysis (039)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
